Stephen Hahn’s dilemma is real:
- The Pfizer vaccine will certainly save lives of those who receive it. It is relatively safe compared to immunizations commonly given to international travelers, but not as safe as a flu shot.
- Unless administered in locations well equipped to handle anaphylactic shock, a few people may die in a very public manner.
- People who die in public view are amplified by the media, transcending numbers and the net benefit of the shot to the public.
- Those few casualties would greatly inhibit uptake of the Pfizer shot, and even safer vaccines yet to come.
- The result would be prolongation of the epidemic, possibly with more total deaths than if approval were denied.